CME and CFTC Clash Over On-Chain Perpetual Futures

A high-stakes battle is unfolding between the U.S. Commodity Futures Trading Commission (CFTC) and the CME Group, the largest derivatives exchange operator in the country. The CFTC recently approved the listing of crypto perpetual futures, also known as 'perps', which are decentralized derivative contracts that enable users to speculate on an asset's price with leverage and no expiration date. The CME Group has responded by filing a lawsuit against the CFTC, arguing that the regulator is mislabeling these products and misapplying the law. According to the CME, futures contracts require an end date, whereas perps are designed to allow traders to take a position on an asset's future price without any deadlines. The CME claims that the CFTC's sudden embrace of perps did not consider the potential consequences and may harm its traditional futures products. The dispute has sparked tensions between the two entities, with the CFTC's chairman, Mike Selig, stating that the CME's decision to challenge the regulator's efforts is 'wholly inappropriate'. The CME's chairman, Terry Duffy, has argued that the CFTC did not follow the proper protocol and may not be prepared to enforce its emerging perps policy. The lawsuit has significant implications for the U.S. approach to the rapidly growing perps market, which reportedly reached $60 trillion in volume last year. The CFTC's decision to allow perps has been seen as a move to open up the U.S. market to these products, but the CME's challenge may hinder this effort. The outcome of the lawsuit will likely have a significant impact on the future of perps in the U.S. and the role of the CFTC in regulating this market.